RESEARCH MONOGRAPH · KDC-MN-371

Liposomal Glutathione

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

60/100

Glutathione in a phospholipid envelope with modestly better PK than free glutathione, the effect size is real but not dramatic

Liposomal glutathione is more interesting than the supplement industry has made it look. The basic delivery rationale is sound: phospholipid encapsulation can protect glutathione from intestinal proteolysis and gamma-glutamyl transpeptidase digestion, improve intestinal absorption through enhanced membrane interaction, and increase systemic bioavailability compared to free reduced glutathione. The pharmacology of liposomal delivery is established for many drugs, so applying it to glutathione is mechanically reasonable.

The Sinha et al 2018 study in healthy adults is one of the more cited data points. Liposomal glutathione (about 1 g daily) over 4 weeks produced measurable increases in whole blood, plasma, and erythrocyte glutathione concentrations, along with effects on glutathione-S-transferase activity and some immune markers (NK cell function). The effect size was modest but the increase in tissue glutathione status was real, which is more than free oral glutathione has consistently produced in similar studies.

The Park 2014 work looking at liposomal glutathione absorption in cell culture and animal models supports the bioavailability advantage over free glutathione, although the magnitude varies by formulation.

What we like about liposomal glutathione for research is that it's a more reliable delivery vehicle for glutathione than free reduced glutathione, particularly for studies where systemic glutathione status manipulation matters. NAC remains a more cost-effective tool for glutathione precursor delivery in most experimental contexts, but for studies specifically requiring intact glutathione delivery (rather than de novo synthesis from cysteine), liposomal is the better choice.

What we dont love is the variability across vendor formulations. Liposome size, lipid composition (phosphatidylcholine variants, cholesterol content), and manufacturing approach significantly affect bioavailability, and there's no standard formulation. Lab-to-lab and product-to-product comparisons need to account for formulation differences, and authentic characterization (DLS for particle size, HPLC for glutathione content, stability under storage) matters more than for simpler compounds.

Sourcing-wise, the formulation chemistry is what determines effectiveness. The active is just reduced glutathione, which is cheap and widely available, but the liposomal preparation is where most of the cost and the variability lives.

From a research standpoint, useful for glutathione delivery studies but not a category-defining tool.

Evidence: 55
Mechanism: 65
Reliability: 58
Safety: 85
Sourcing: 60
Value: 50
Signal: 55
Staying power: 55

Plain-language summary Intrigue 50 / 100

Liposomal glutathione is the body's master antioxidant (a small protein called glutathione, or GSH) packaged inside tiny fat bubbles called liposomes. The trick is delivery. Plain oral glutathione is largely destroyed in the gut, so the liposome shell is meant to protect it long enough to reach the bloodstream and possibly take a lymphatic shortcut. A handful of small clinical studies suggest it raises blood and intracellular glutathione better than plain oral glutathione, but the picture is far from settled. Many researchers argue NAC (which lets cells build their own glutathione) does the same job for less money. Used in oxidative-stress research and as a supplement. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Glutathione (liposomal formulation)

L-glutathione encapsulated in phospholipid liposomes for improved oral absorption.

Abstract

Liposomal glutathione (L-glutathione encapsulated in phosphatidylcholine-based liposomes; native GSH CAS 70-18-8; molecular formula C10H17N3O6S; molecular weight 307.32) is a delivery system for the master antioxidant glutathione developed to address the poor oral bioavailability of native glutathione. The phospholipid bilayer protects the tripeptide from gastric and intestinal proteolysis and may facilitate intestinal uptake through chylomicron-mediated lymphatic absorption. Limited published clinical trials suggest improved plasma and intracellular glutathione elevation compared to non-liposomal oral forms, though comparative effectiveness against NAC (which raises GSH via biosynthesis rather than direct delivery) is debated. Used as a research-grade and supplement-grade glutathione formulation.

Mechanism of action

Phospholipid liposome encapsulation of L-glutathione; protects from proteolysis and may facilitate intestinal absorption.

Reported research dose ranges

Supplement use 250 to 500 mg in the published literature.

References

Sinha R, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr 2018.
Schmitt B, et al. Effects of N-acetylcysteine, oral glutathione, and acetylated glutathione on glutathione levels. Redox Biol 2015.
Witschi A, et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol 1992.

Read the full monograph

The full reference document is available as a research-use-only PDF download. Note: PDFs for newly added compounds may take a few hours to propagate after this article was published.

KDC-MN-371

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Liposomal Glutathione

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs